News | Radiation Therapy | June 29, 2017

Multiple Uses for Gamma Knife to Drive Market Growth Through 2025

Multiple market reports indicate that as doctors discover new ways to utilize Gamma Knife radiosurgery, the global market for this innovative surgical method is growing.

Multiple Uses for Gamma Knife to Drive Market Growth Through 2025

June 29, 2017 — Due to its widespread success in treating several types of brain cancer, global market growth for Gamma Knife radiosurgery involving the head is expected to exceed $364.8 million by 2025. As more patients seek treatment at facilities that offer Gamma Knife radiosurgery, the market is forecast to grow at a compound annual growth rate (CAGR) of 9.2 percent, according to a new report from public relations firm OpenPR.

In terms of geographical location, North America has traditionally led market revenue share, accounting for over 29.2 percent of revenue in 2014, according to the report. A separate report from Future Market Insights indicates that by 2025, treatment of brain metastasis is expected to account for over $285.7 million in the United States market alone. However, as more patients worldwide are treated using Gamma Knife for a variety of medical conditions (for example, brain metastases, benign brain tumors such as pituitary adenomas, meningiomas and acoustic neuromas), both the European and Asia Pacific markets are expected to expand at CAGRs of 7.7 percent and 10.5 percent, respectively.(1)

A large part of this growth is the confirmation of the Gamma Knife an effective treatment option for a wide variety of medical conditions that benefit from a precision approach. Beyond its use as a successful therapy for metastatic brain tumors, the Gamma Knife has provided powerful results to patients suffering from trigeminal neuralgia, movement disorders and arteriovenous malformations, according to the San Diego Gamma Knife Center.

Kenneth Ott, MD, FACS, neurosurgeon at SDGKC, said, “The need for the radiosurgical treatment of metastatic brain tumors is vast and growing. Radiosurgery will also play an important part in the emerging field of neuro-augmentation. Stereotactic functional neurosurgery for pain, obsessive compulsive disorders, seizure disorders and other functional brain disorders will provide further patients to Gamma Knife facilities.”

Additionally, as more patients become aware of the advantages of radiosurgery, there is an increasing demand for this minimally invasive surgical method which has proven to be painless and less time-consuming. Support from governmental agencies, which are increasingly interested in initiatives focused on advancing the practice of radiosurgery, will further drive market growth as more healthcare facilities receiving government funding turn to the practice, according to the FMI report.

“As the nationwide cost of medical care and facilities continued to increase, it is increasingly important to healthcare facilities to provide cost-efficient treatment, such as radiosurgery,” said Ott. “Single treatment in a few hours, in an outpatient facility avoids the cost of in-patient care and the complications necessitated by open surgery. Patients are increasingly aware that co-pay and deductible costs are reduced with Gamma Knife radiosurgery.”

For more information: www.sandiegogammaknife.com

Related Content

Merit Medical Completes Acquisition of Cianna Medical
News | Women's Health | November 14, 2018
Disposable device manufacturer Merit Medical Systems Inc. announced the closing of a definitive merger agreement to...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...
Proton Therapy for Pediatric Brain Tumors Has Favorable Cognitive Outcomes
News | Proton Therapy | November 06, 2018
Proton therapy treatment for pediatric brain tumor patients is associated with better neurocognitive outcomes compared...
The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

The patient’s wife changes the Optune array. Clinical trials indicate that the electrical fields emitted by Optune have the potential to lengthen the lives of patients with glioblastoma.

Feature | Radiation Oncology | November 06, 2018 | By Greg Freiherr
Approximately 11,000 professionals attended the four-day meeting of the...